Results from Outreach: A Phase 2 Study of Lisocabtagene Maraleucel (Liso-cel) Administered As Outpatient (Outpt) or Inpatient (Inpt) Treatment in the Community/Nonuniversity Setting in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) Meeting Abstract

Industry Collaboration

cited authors

  • Linhares, Yuliya; Freytes, Cesar; Cherry, Mohamad; Bachier, Carlos; Maris, Michael; Hoda, Daanish; Varela, Juan Carlos; Bellomo, Courtney; Cross, Scott; Essell, James; Fanning, Suzanne; Terebelo, Howard; Yimer, Habte; Courtright, Jay; Sharman, Jeff P.; Vedal, Min; Mailley, Connor; Espinola, Ricardo; Mattar, Bassam

authors

Publication Date

  • November 15, 2022

webpage

published in

category

start page

  • 10416

end page

  • 10418

volume

  • 140